UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats

Clinical science (1979), 2012-06, Vol.122 (12), p.581-590

2012

Volltextzugriff (PDF)

A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation Factor XII (FXIIa)

Journal of immunological methods, 2012-02, Vol.376 (1-2), p.132-138

2012

Volltextzugriff (PDF)

A Prospective Study of Apixaban for Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patients: Catheter 3

Blood, 2022-11, Vol.140 (Supplement 1), p.1245-1246

2022

Volltextzugriff (PDF)

The role of recombinant factor VIIa in on-pump cardiac surgery : Proceedings of the Canadian Consensus Conference

Canadian journal of anesthesia, 2007-07, Vol.54 (7), p.573-582

2007

Volltextzugriff (PDF)

Peak plasma rivaroxaban levels in patients weighing 120 kg or greater

Thrombosis research, 2021-05, Vol.201, p.15-17

2021

Volltextzugriff (PDF)

Peak Plasma Rivaroxaban Levels in Individuals Weighing over 120 Kilograms

Blood, 2017-12, Vol.130, p.1112-1112

2017

Volltextzugriff (PDF)

Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women

Trials, 2001-01, Vol.2 (3), Article 141

2001

Volltextzugriff (PDF)

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Blood, 2016-12, Vol.128 (22), p.90-90

2016

Volltextzugriff (PDF)

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Blood, 2017-12, Vol.130 (Suppl_1), p.LBA-6-LBA-6

2017

Volltextzugriff (PDF)

Inter-observer reliability of the HERDOO2 clinical decision rule

Thrombosis research, 2016-05, Vol.141, p.136-138

2016

Volltextzugriff (PDF)

CD109 is expressed on a subpopulation of CD34 + cells enriched in hematopoietic stem and progenitor cells

Experimental hematology, 1999-08, Vol.27 (8), p.1282-1294

1999

Volltextzugriff (PDF)

Low Dose Oral Vitamin K Does Not Increase Time in Therapeutic Range: Results of a Multicentre Clinical Trial

BLOOD, 2014-12, Vol.124 (21), p.2872-2872

2014

Volltextzugriff (PDF)

Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins

Blood, 2002-03, Vol.99 (5), p.1683-1691

2002

Volltextzugriff (PDF)

Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteins

Blood, 2002-03, Vol.99 (5), p.1683-1691

2002

Volltextzugriff (PDF)

Diagnosing PNH with FLAER and multiparameter flow cytometry

Cytometry. Part B, Clinical cytometry, 2007-05, Vol.72B (3), p.167-177

2007

Volltextzugriff (PDF)

Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2015-10, Vol.3 (4), p.347-353.e1

2015

Volltextzugriff (PDF)

Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale

Canadian journal of neurological sciences, 2007-02, Vol.34 (1), p.74-80

2007

Volltextzugriff (PDF)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia

Journal of vascular surgery cases, 2015-12, Vol.1 (4), p.246-248

2015

Volltextzugriff (PDF)

Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial

BMC cardiovascular disorders, 2007-07, Vol.7 (1), p.21-21, Article 21

2007

Volltextzugriff (PDF)

Prospective Evaluation of An Argatroban Dosing Nomogram Using the Ecarin Chromogenic Assay at a Tertiary Institution

Blood, 2008-11, Vol.112 (11), p.3016-3016

2008

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(81)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Humans
(32)
Life Sciences & Biomedicine
(31)
Animals
(10)
Technology
(10)
Biological And Medical Sciences
(9)
Male
(8)
Materials Science
(8)
Female
(7)
Hematology
(7)
Materials Science, Multidisciplinary
(7)
Middle Aged
(7)
Physical Sciences
(7)
Aged
(6)
Cardiovascular System & Cardiology
(6)
Flow Cytometry
(6)
Mice
(6)
Adult
(5)
Cell Biology
(5)
Electrochemistry
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats

A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation Factor XII (FXIIa)

A Prospective Study of Apixaban for Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patients: Catheter 3

The role of recombinant factor VIIa in on-pump cardiac surgery : Proceedings of the Canadian Consensus Conference

Peak plasma rivaroxaban levels in patients weighing 120 kg or greater

Peak Plasma Rivaroxaban Levels in Individuals Weighing over 120 Kilograms

Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Inter-observer reliability of the HERDOO2 clinical decision rule

CD109 is expressed on a subpopulation of CD34 + cells enriched in hematopoietic stem and progenitor cells

Low Dose Oral Vitamin K Does Not Increase Time in Therapeutic Range: Results of a Multicentre Clinical Trial

Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins

Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteins

Diagnosing PNH with FLAER and multiparameter flow cytometry

Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis

Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale

The Effectiveness Of 30-40 Mm Hg Compression Stockings To Treat Acute Leg Pain Associated With Proximal Deep Vein Thrombosis: Results From The Sox Randomized Controlled Trial

Predictors Of The Post-Thrombotic Syndrome In a Large Cohort Of Patients With Proximal DVT: Secondary Analysis Of The Sox Trial

Inflammation Markers and The Risk Of Post Thrombotic Syndrome: Results From The Bio-Sox Study

A Multicenter Randomized Placebo Controlled Trial of Compression Stockings to Prevent the Post-Thrombotic Syndrome After Proximal Deep Venous Thrombosis: The S.O.X. Trial

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia

Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial

Prospective Evaluation of An Argatroban Dosing Nomogram Using the Ecarin Chromogenic Assay at a Tertiary Institution

Aktive Filter

Suchergebnisse filtern